Market Research Blog – Page 547 – New Product Development

Global Thyroid Function Test Market Poised for Steady Growth: Expected to Reach USD 2.64 Billion by 2033

The global thyroid function test market, valued at USD 1.75 billion in 2023, is set to achieve robust growth, reaching an estimated USD 2.64 billion by 2033. With a compound annual growth rate (CAGR) of 4.2%, this growth trajectory underscores the growing need for efficient diagnostic solutions amid rising thyroid-related health issues worldwide.

Thyroid Function Test Market Trends and Drivers:

The thyroid function test market is experiencing steady growth driven by increased prevalence of thyroid disorders globally. Changes in lifestyle, rising obesity rates, and hormonal imbalances are contributing factors. The World Obesity Atlas 2023 projects that by 2025, the number of overweight or obese individuals will reach 3,041 million, highlighting the need for early and effective diagnosis of thyroid-related health conditions.

Key trends fueling this growth include:

Rising Prevalence of Thyroid Disorders
- Conditions such as hypothyroidism, hyperthyroidism, and thyroid cancer are becoming more widespread, leading to increased demand for diagnostic tests.
Technological Advancements
- Innovations in thyroid function testing have resulted in more sensitive and accurate assays, enabling early diagnosis and better monitoring of thyroid disorders.
Point-of-Care Testing Devices
- User-friendly, rapid diagnostic tools are gaining traction, improving accessibility and convenience for patients and healthcare providers.
Focus on Thyroid Cancer Diagnosis
- The rise in thyroid cancer cases emphasizes the need for advanced diagnostics, such as molecular diagnostics and fine needle aspiration (FNA) techniques, to distinguish between benign and malignant thyroid nodules.

Market Implications:

The growing awareness of thyroid health and the demand for improved diagnostic methods underscore the importance of investing in advanced testing technologies. With innovations enabling quicker, more precise results, healthcare providers are better equipped to deliver timely and effective care.

The steady rise in thyroid-related health issues is a call to action for stakeholders to prioritize research, innovation, and accessibility in thyroid diagnostics. As the market continues its upward trajectory, industry leaders must remain committed to addressing the evolving needs of patients and practitioners worldwide.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Key Takeaways: Global Thyroid Function Test Market Insights (2023-2033)

Market Overview
- Valuation: Market worth US$ 1.75 billion in 2023, projected to reach US$ 2.64 billion by 2033.
- CAGR: Robust growth at 2% CAGR, driven by rising thyroid-related health issues and demand for efficient diagnostics.
Regional Highlights
- United States:
  - Growth at 5% CAGR due to rising obesity rates and government-funded endocrinology studies.
  - Advances in thyroid hormone research and newborn screenings boost the market.
- India:
  - Predicted 2% CAGR, spurred by increasing awareness, government programs, and affordable testing options.
  - High demand for pregnancy-related thyroid tests and genetic disorder diagnostics.
- China:
  - Expected 1% CAGR, driven by healthcare reforms and rising middle-class income.
  - Environmental factors like iodine imbalances fuel demand for thyroid testing.
- United Kingdom:
  - Growth at 3% CAGR, with rising autoimmune and thyroid disorder cases.
  - Investments in R&D and diagnostic infrastructure to propel market growth.
- Germany:
  - CAGR of 8% driven by innovative diagnostic methods and increased demand for point-of-care systems.
  - Regulatory frameworks and routine screening programs to enhance market adoption.

Key Drivers of Growth
- Rising prevalence of obesity and thyroid disorders globally.
- Increased awareness and early diagnosis initiatives.
- Development of cost-effective thyroid cancer detection methods.
- Growing healthcare infrastructure in emerging economies.
- Advancements in preventive treatments and point-of-care diagnostic systems.
Future Outlook
- Promising progress in detecting hyperthyroidism and Grave’s disease.
- Increased focus on R&D to innovate thyroid diagnostics and treatments.
- Expanding healthcare access in densely populated regions like China and India.

Competitive Landscape:

Thyroid function test companies continue to strengthen their market position through strategic initiatives such as mergers, acquisitions, partnerships, and product line expansions. These growth strategies are further bolstered by robust investments in research and development.

In February 2023, Parkway Laboratories expanded its test offerings with the introduction of the Thyroid Screen in Pregnancy (code: TSP). This new profile mirrors the components of the thyroid screen basic profile (code: TS1) while incorporating trimester-specific reference intervals.
In October 2023, Lassen Therapeutics unveiled the final results of preclinical studies on LASN01 for Thyroid Eye Disease (TED) at the American Thyroid Association (ATA) meeting. The study demonstrated that LASN01 effectively suppressed TED orbital fibroblast proliferation, reduced hyaluronan secretion, and exhibited anti-fibrotic activity. These findings position LASN01 as a promising therapeutic candidate for TED.

Key Companies Profiled:

Danaher Corporation
DiaSorin
F.Hoffmann-La Roche AG
Merck KGaA
Biomerieux
Abbott Laboratories
ThermoFisher Scientific
Qualigen Inc.
KRONUS
Diagnostic Automation/Cortez Diagnostics Inc.

Segmentation Analysis of the Thyroid Function Test Market:

By Test Type:

By End Use:

Clinics
Research Organizations
Diagnostic Laboratories
Hospitals

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Backflow Preventers Market to Reach USD 13.8 Billion by 2033, Growing at a 4.5% CAGR

The global backflow preventers market is poised to reach a valuation of USD 8.7 billion by the end of 2022. This growth trajectory is attributed to the ongoing efforts of companies in introducing technologically advanced backflow preventers, featuring innovative materials such as stainless steel, ductile iron, and high-performance plastics. Over the forecast period from 2023 to 2033, the market is projected to witness a steady expansion, with an estimated value of USD 13.8 billion by 2033, reflecting a compounded annual growth rate (CAGR) of 4.5%. In the immediate future, the market is anticipated to achieve a milestone of USD 8.9 billion in 2023, signaling a promising start to the forecast period.

Backflow preventers are crucial components of plumbing systems designed to ensure the safety of potable water supplies. These devices work by preventing the reverse flow of contaminated water back into the main water supply lines, thus safeguarding against the risk of water contamination and ensuring water quality standards are maintained. Backflow preventers are commonly installed in various settings, including residential, commercial, and industrial buildings, as well as in municipal water supply systems.

Get Exclusive Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7412

Demand Factors

Rising Adoption of Backflow Preventers in Emerging Economies Such as India and China

Growing Awareness of Health and Liability Risks Associated with Water Contamination

Surge in Residential Construction Projects Fuels Demand for Backflow Preventers

Technological Advancements Enhance Performance and Efficiency of Backflow Preventers

Key Players

Watts Water Technology Company
Emerson Electric Co.
Honeywell International Inc.
Conbraco Industries
Zurn Industries LLC
Caleffi S.p.a.
Hans Sasserath GmBH & Co, KG
W. W. Grainger Inc
Talis Management Holding GmBH
A. R. I. Flow Control

Key Segments

By Product Type:

Atmospheric Vacuum Breaker
Pressure Vacuum Breaker
Double Check Valve Assembly
Reduced Pressure Zone

By Material Type:

Stainless Steel
Plastic
Ductile Iron
Bronze
Other Materials

By End Use:

Residential
Commercial
Industrial

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Regenerative Medicine Market to Skyrocket to USD 73,084.2 Million by 2033 at a 18.5% of CAGR

The global regenerative medicine market is set to witness explosive growth, with its valuation expected to surge from US$ 13,385.6 million in 2023 to an impressive US$ 73,084.2 million by 2033, according to the latest industry analysis. This reflects a robust compound annual growth rate (CAGR) of 18.5% over the forecast period. The rise in precision medicine, increased investment in regenerative medicine research, and advances in cell manufacturing and bioprocessing are the key factors driving market growth.

Regenerative medicine, which focuses on restoring the function of damaged tissues and organs, is gaining momentum due to advancements in cancer biologics and 3D disease modeling technologies. The ability to simulate human disease conditions in a 3D environment allows for more precise testing of regenerative therapies, accelerating their path to clinical use. This technological shift is expected to drive the adoption of regenerative medicine in clinical settings.

Investments in stem cell banking, cell manufacturing, and bioprocessing facilities are further supporting the commercialization and accessibility of regenerative therapies. These investments are enabling the large-scale production of stem cells and biologics, reducing production costs and facilitating wider access to advanced therapies. Precision medicine, especially in the area of cancer treatment, is also expected to drive demand for personalized regenerative medicine solutions.

With breakthroughs in bioprocessing, 3D disease modeling, and stem cell research, the regenerative medicine industry is on track for unprecedented growth. The increased commercialization of regenerative therapies, combined with growing interest from investors and healthcare providers, is expected to create lucrative opportunities for pharmaceutical companies, research institutions, and biotech firms.

Get the Comprehensive Full Report Now – https://www.futuremarketinsights.com/reports/regenerative-medicine-market

Key Takeaways:

The global regenerative medicine market is projected to grow from US$ 13,385.6 million in 2023 to US$ 73,084.2 million by 2033, at an impressive CAGR of 18.5%.
Growth is driven by advances in cancer biologics, 3D disease modeling, and the rise of precision medicine.
Increased investments in stem cell banking, cell manufacturing, and bioprocessing are supporting the commercialization and large-scale production of regenerative therapies.
Emerging manufacturing technologies like 3D human disease models are facilitating faster testing and validation of regenerative therapies.
The growing demand for personalized, precision-based treatments is expected to fuel market expansion, creating lucrative opportunities for biotech firms, healthcare providers, and pharmaceutical companies.

Key Trends in the Regenerative Medicine Industry

Increased Development of Regenerative Products: There is a growing focus on developing regenerative medicine products, supported by significant investments in research and development.
Advancements in Precision Medicine: As cancer biologics advance, the field of precision medicine is expected to expand, allowing for more tailored treatments for patients.
Innovations in Manufacturing Technologies: The use of advanced manufacturing technologies, such as 3D models of human diseases, is facilitating the testing of regenerative medicine approaches in clinical settings.
Investment in Stem Cell Banking and Bioprocessing: Growing investments in stem cell banking, cell manufacturing, and bioprocessing facilities are enhancing the commercialization and accessibility of regenerative therapies.
Changing Societal Attitudes: There is a notable shift in societal attitudes towards pet animals and animal farming, which is driving demand for regenerative solutions in veterinary medicine as well.
Demand for Fast and Reliable Diagnostics: The increasing need for quick and effective diagnostic techniques in regenerative medicine is creating opportunities for innovation.

Competitive Landscape

With several competitors in regenerative medicine, the overall industry is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as divestiture, partnerships and collaborations, and new therapy launches.

Some of the developments by players in the regenerative medicine industry are given below

In January 2022 – Stryker’s president joins the board of the regenerative medicine company Collagen Matrix, which will accelerate the growth strategy and further their vision of improving patient lives through innovative regenerative devices
In January 2021, Integra LifeSciences Holdings Corporation divestiture of its Extremity Orthopaedics business to Smith & Nephew, which will contribute to technologies in orthopedics and regenerative medicines.

Key Companies Profiled

3M
Allergan plc
Amgen, Inc.
Aspect Biosystems
bluebird bio
Kite Pharma
Integra LifeSciences Holdings Corporation
MEDIPOST Co., Ltd.
Anterogen Co., Ltd.
MiMedx Group
Misonix, Organogenesis Inc.
Orthocell Limited
Corestem, Inc.
Spark Therapeutics
APAC Biotech
Shenzhen Sibiono
GeneTech Co., Ltd.
Smith & Nephew plc
Stryker Corporation

Key Industry Segments Covered In Regenerative Medicine Industry Research

By Therapy type:

Cell Therapy
- Autologous Cell Therapy
- Allogenic Cell Therapy
Stem Cell Therapy
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Tissue-engineering
Gene Therapy

By Application:

Wound Care
Musculoskeletal
Oncology
Dental
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Inflammatory & Autoimmune Diseases
Other Therapeutic Applications

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:

Autism Spectrum Disorder Management Market
Atrial Appendage Occluder Market
Cell Culture Incubator Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Key Trends Driving Growth in the Fatty Amine Market: Applications, Innovation, and Sustainability

The global fatty amine market is expected to exhibit steady growth at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2033. By 2033, the market is anticipated to reach a valuation of USD 4,955.9 million, driven by increasing applications across industries such as agriculture, water treatment, and personal care. Fatty amines are widely used as emulsifiers, corrosion inhibitors, and anti-caking agents, which, coupled with rising demand in emerging economies, are fueling market expansion.

The increased demand for fatty amine as a corrosion inhibitor, water softener, and scale dispersant is one of the primary drivers driving the industry. Fatty amine is used for wastewater treatment in various industrial facilities, refineries, and manufacturing industries, which has led to increased demand within the water treatment business.

Water supplies have been under significant strain in recent years due to the rising global population, increased demand for clean water in industrial applications, and the impact of climate change, which has resulted in water scarcity worldwide, necessitating the need for water filtration activities. Factors such as these have been propelling the growth of the fatty amine industry.

Key Industry Trends and Highlights: Fatty Amine Market

Diverse Sector Applications
The rising demand for fatty amines is driving growth across multiple industries, including agrochemicals, surfactants, and personal care products, due to their versatile properties and wide-ranging uses.
Technological Advances
Continuous research and development efforts are enhancing the quality and adaptability of fatty amines, leading to improved production methods and innovative applications.
Sustainable Practices
A growing emphasis on environmentally friendly uses and sustainable manufacturing processes is fueling innovation and fostering increased demand for fatty amines globally.

Access the Complete Report for a Comprehensive Overview!

Top Players in the Fatty Amine Industry

Clariant AG
Albemarle Corporation
Akzo Nobel N.V.
Evonik Industries AG
Kao Corporation
Arkema S.A.
Eastman Chemical Company
Solvay S.A.
E.I. du Pont de Nemours & Co.
Procter & Gamble Company
Lonza Group Ltd
Indo Amine Ltd
Sterling Auxiliaries Pvt. Ltd.
Wuxi Zhufeng Fine Chemical Co., Ltd.
NOF CORPORATION
Nouryon

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the fatty amine industry, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the fatty amine industry, the industry is segmented on the basis of product type (primary amines, secondary amines, and tertiary amines), end use (agrochemicals, water treatment, construction, oil field chemicals, personal care, textile industry, others) and across seven major regions (North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East & Africa).

About Future Market Insights (FMI)

Contact Us:

Veterinary Molecular Diagnostics Market to Double in Value, Reaching USD 377.22 Million by 2033 at a 6.84% of CAGR

Global Veterinary Molecular Diagnostics Industry — Veterinary Molecular Diagnostics Market

The global veterinary molecular diagnostics market is poised for significant growth, with its valuation projected to rise from US$ 194.47 million in 2023 to US$ 377.22 million by 2033. This represents a compound annual growth rate (CAGR) of 6.84% over the forecast period, according to the latest industry analysis. The increasing demand for fast and accurate diagnostic techniques, coupled with advancements in veterinary healthcare, is driving market expansion.

Key growth drivers include the adoption of multiple testing panels, growing consolidation in the veterinary diagnostics industry, and the rising global population of pet animals. As pet ownership increases, so does the demand for better healthcare services for animals, leading to increased spending on veterinary health. Moreover, the development of the animal farming sector and a shift in societal attitudes toward pet care are further boosting the demand for veterinary molecular diagnostics.

The market is also being shaped by technological advancements in diagnostic methods. Molecular diagnostics, which offer high accuracy, speed, and reliability, are increasingly being adopted by veterinary clinics, research institutions, and animal health companies. This shift is allowing for faster detection of infectious diseases, genetic disorders, and other health conditions in animals, thereby improving treatment outcomes and reducing disease transmission risks.

With growing investments in veterinary healthcare and the increasing importance of animal welfare, the veterinary molecular diagnostics market is expected to continue its upward trajectory. Industry players are focusing on product innovation and the development of portable, easy-to-use diagnostic devices to cater to the rising demand for point-of-care testing solutions in veterinary care.

Key Takeaways:

The global veterinary molecular diagnostics market is expected to grow from US$ 194.47 million in 2023 to US$ 377.22 million by 2033, at a CAGR of 6.84%.
Growth is driven by increased adoption of multiple testing panels, consolidation in the veterinary diagnostics industry, and rising pet ownership worldwide.
Technological advancements in molecular diagnostics are enabling faster, more accurate detection of animal diseases, driving demand for point-of-care solutions.
The development of the animal farming sector, coupled with societal shifts toward enhanced pet care, is expected to create sustained market growth opportunities.
Key industry players are focusing on innovations in diagnostic tools to meet the growing demand for fast, accurate, and user-friendly veterinary testing solutions.

Access the Full Report – https://www.futuremarketinsights.com/reports/veterinary-molecular-diagnostics-market

Key Market Drivers

Rising Adoption of Multiple Testing Panels: The increasing use of comprehensive testing panels for diagnosing various animal diseases is driving demand in the market.
Consolidation in the Veterinary Diagnostics Industry: The growing consolidation among companies in the veterinary diagnostics sector is enhancing capabilities and expanding product offerings.
Growing Pet Population: An increase in the global pet population is leading to higher demand for veterinary care and diagnostics.
Increased Animal Health Spending: Rising expenditures on animal health, including diagnostics, are contributing to market growth.
Advancements in Veterinary Molecular Diagnostics: Innovations in diagnostic technologies are improving the speed and accuracy of disease detection in animals.
Developments in Animal Farming: Changes in societal attitudes towards pet ownership and advancements in the animal farming sector are further boosting the demand for effective diagnostic solutions.
Demand for Fast and Reliable Diagnostic Techniques: The need for quick and accurate diagnostic methods is increasing, with molecular diagnostics being well-positioned to meet this demand.

Key Companies Profiled

bioMérieux SA
IDEXX Laboratories, Inc.
Neogen Europe, Ltd.
Veterinary Molecular Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
ID-Vet, Qiagen N.V.

Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis

By Product Type:

PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits
INAAT Kits
Microarray Kits
DNA Sequencing Kits

By Species Type:

Livestock Animals
- Equine
- Porcine
- Poultry
- Cattle
- Aquatic
- Ovine
Companion Animals
- Canine
- Feline
- Avian

By Disease Type:

Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

By End User:

Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:

Mammography Market
DNA-Based Skin Care Market
3D Surgical Microscope Systems Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bio-Plastic Industry: Driving Sustainability Through Circular Economy and Innovation

The global bio-plastics market is poised for remarkable growth, with its valuation projected to reach an impressive USD 1,353.3 billion by 2033. Driven by increasing demand for sustainable and eco-friendly materials, the market is expected to surge at a robust CAGR of 30.2% during the forecast period from 2023 to 2033. This exponential growth is fueled by rising environmental awareness, regulatory support for biodegradable alternatives, and advancements in bio-based polymer technologies, making bio-plastics a preferred choice across industries such as packaging, automotive, and consumer goods.

One of the major factors contributing to the growth of the bio-plastic market is the reduction in greenhouse gas emissions. Bio-plastics often have a lower carbon footprint compared to traditional plastics, contributing to efforts to reduce greenhouse gas emissions and combat climate change.

Bio-plastics are being used in innovative packaging solutions, such as edible packaging, which can reduce food waste and offer convenience to consumers. The automotive industry is exploring bio-plastics for interior and exterior components to reduce vehicle weight and improve fuel efficiency, presenting a significant growth opportunity.

Advances in biotechnology and genetic engineering are enabling the production of bio-plastics from engineered microorganisms and agricultural feedstocks, potentially improving scalability and cost-effectiveness. The expansion of bio-plastics into a broader range of applications, including 3D printing, electronics, and toys, diversifies market opportunities.

Key Drivers of the Bio-Plastic Market

Rising Environmental Awareness:
- Increasing concerns about environmental degradation and the need for sustainable alternatives to traditional plastics.
- Growing demand from consumers and businesses seeking eco-friendly options to reduce carbon footprints.
Supportive Government Policies:
- Implementation of stringent regulations aimed at reducing plastic waste and encouraging the use of sustainable materials.
- Tax incentives and subsidies for adopting bio-plastics, fostering market growth.
Petroleum Price Volatility:
- Fluctuating oil prices make bio-plastics more attractive as they are derived from renewable resources.
- Reduced dependence on fossil fuels enhances cost-competitiveness of bio-plastics.
Advancements in R&D:
- Ongoing innovations improving the properties and performance of bio-plastics.
- Enhanced versatility and suitability for diverse applications across industries.

Discover the Future of Bio-Plastic Market with Our Detailed Report!

Leading Players in the Market

BASF SE
NatureWorks LLC
Toray Industries Inc.
Evonik Industries
E. I. du Pont de Nemours and Company
DSM N.V
Arkema
Techno Polymer Co. Ltd.
RTP Company

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global bio-plastic market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the bio-plastic market, the market is segmented on the basis of material type (bio-PET, bio-PE, bio-PA, bio-degradable polyesters, PLA & PLA blends, starch blends, PHA, and others ), and applications (bottle, packaging, food-services, agriculture/horticulture, consumer products, and automotive), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East & Africa (MEA)).

About Future Market Insights (FMI)

Contact Us:

Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% of CAGR , Driven by Rising Demand for Advanced Drug Formulations

Future Market Insights (FMI) has released an updated analysis of the pharmaceutical excipient market, projecting steady growth over the next decade. The market is expected to be valued at US$ 972.9 million in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 5.1%, reaching a valuation of US$ 1.6 billion by 2034. The rising demand for innovative drug formulations, enhanced bioavailability, and advanced delivery systems are key factors driving this market expansion.

Pharmaceutical excipients play a critical role in drug development, acting as stabilizers, binders, and carriers that improve the efficacy, safety, and shelf life of medications. The increased emphasis on patient-centric drug delivery methods, such as controlled-release and targeted delivery systems, is fueling the demand for next-generation excipients. This trend is being further accelerated by the growing production of biologics, complex generics, and personalized medicines.

As the pharmaceutical industry shifts toward more sophisticated drug formulations, manufacturers are increasingly focusing on the development of multifunctional excipients that can meet regulatory standards while enhancing drug performance. The rising prevalence of chronic diseases and an aging population are also driving the need for improved drug delivery mechanisms, further supporting the growth of the excipient market.

The pharmaceutical excipient market is expected to witness continued growth opportunities as industry stakeholders, including pharmaceutical companies and research organizations, prioritize innovations in drug formulation. With regulatory agencies encouraging the adoption of quality-by-design (QbD) approaches, the demand for high-performance excipients is projected to rise significantly over the next decade.

Key Takeaways:

The pharmaceutical excipient market is expected to grow from US$ 972.9 million in 2024 to US$ 1.6 billion by 2034, at a CAGR of 5.1%.
Growth is driven by the increasing adoption of advanced drug delivery systems, biologics, and patient-centric drug formulations.
Excipients play a crucial role in enhancing the stability, bioavailability, and effectiveness of drug formulations.
Regulatory support for quality-by-design (QbD) approaches and the rise in personalized medicines are creating new growth opportunities for pharmaceutical excipient manufacturers.

Get Complete Full Report – https://www.futuremarketinsights.com/reports/pharmaceuticals-excipients-market

Key Market Drivers

Increasing Demand for Generic and Biologic Drugs: The rising production and consumption of generic medications and biologics are driving the demand for pharmaceutical excipients, which play a crucial role in drug formulation.
Growth of the Pharmaceutical Industry: An expanding pharmaceutical sector, particularly in emerging markets, is contributing to the increased need for excipients that enhance drug delivery and stability.
Rising Geriatric Population: An aging population with a higher prevalence of chronic diseases requires more medications, thereby increasing the demand for effective excipient solutions.
Technological Advancements: Innovations in excipient formulations, including multifunctional excipients that can serve multiple purposes in drug delivery systems, are fostering market growth.
Regulatory Support for Drug Development: Favorable regulatory environments and initiatives aimed at accelerating drug approvals are encouraging investments in excipient research and development.

Challenges

Stringent Regulatory Frameworks: The complex regulatory landscape can pose challenges for manufacturers seeking to introduce new excipients or formulations into the market.
High Development Costs: The costs associated with developing new excipients can be significant, potentially limiting opportunities for smaller companies.

Competitive Landscape in the Pharmaceutical Excipient Market

The pharmaceutical excipient industry is highly competitive, with newer entrants looking to distinguish themselves with novel products. On the other hand, established players are looking to expand production facilities to meet production targets.

One of the prominent companies in the market, Ashland Global Holdings, is looking to expand its portfolio with the help of biologics. As the company’s drug delivery focus enhances, even greater attention is being paid to excipients. Croda International, meanwhile, is looking to increase its functional excipients portfolio.

Recent Developments

In October 2023, India-based Clariant Chemicals announced plans to launch three new excipients as part of its VitiPure range.
In September 2023, United States-based Colorocon introduced its titanium dioxide (TiO2)-free Opadry film coating system for tablets to stop moisture from affecting them.
In November 2021, French-based Gattefossé launched three new pharmaceutical excipients, named Labrafac MC60, Gelucire 59/14, and Emulfree Duo.

Key Companies in the Pharmaceutical Excipient Market

Ashland Global Holdings
Croda International
BASF SE
Lubrizol Corporation
Evonik Industries AG
Associated British Foods
Roquette Feres
Archer Daniels Midland Company
DuPont
Avantor Performance Materials, Inc.
The Dow Chemical Company
FMC Corporation
Evonik Industries
Lubrizol Corporation
Roquette
Colorcon, Inc.

Key Segments

By Type:

Organic Chemicals
Oleochemicals
- Fatty Alcohols
- Mineral Stearates
- Glycerin
- Other Oleochemicals
Carbohydrates
- Sugars
  - Actual Sugars
  - Sugar Alcohols
  - Artificial Sweeteners
- Cellulose
  - Microcrystalline cellulose
  - Cellulose ethers
  - Carboxymethyl cellulose (CMC) and croscarmellose sodium
  - Cellulose esters
- Starch
  - Modified Starch
  - Dried Starch
  - Converted Starch
Petrochemicals
- Glycols
- Povidones
- Mineral Hydrocarbons
- Acrylic Polymers
- Other Petrochemical Excipients
Proteins
Other Organic Chemicals
Artificial
Calcium Phosphate
Metal Oxides
Halites
Calcium Carbonate
Calcium Sulphate
Other Artificial Chemicals
Other Chemicals

By Technique:

Fillers & Diluents
Suspending & Viscosity
Coating
Binders
Flavoring & Sweeteners
Disintegrants
Colorants
Lubricants & Glidants
Preservatives
Emulsifying

By Formulation:

Oral Formulations
Tablets
Capsules
- Hard-gelatin Capsules
- Soft-gelatin Capsules
Liquid Formulations
Other Oral Formulations
Topical Formulations
Parenteral Formulations
Other Formulations

By Application:

Taste Masking
Stabilizers
Modified-Release
Solubility & Bioavailability Enhancement
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:

Focused Ultrasound System Market
MRI-Safe Neurostimulation Systems Market
Multi-channel Remote ECG Monitors Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Biobased Biodegradable Plastic Market: Driving Sustainability Across Industries with Innovative Solutions

The global biobased biodegradable plastic market is poised for significant growth, projected to expand at a robust CAGR of 10% from 2023 to 2033. Rising from its current valuation, the market is anticipated to reach an impressive USD 13.6 billion by the end of the forecast period. This surge is driven by increasing environmental awareness, stringent regulations promoting sustainability, and the growing adoption of eco-friendly alternatives across various industries, including packaging, agriculture, and consumer goods. Innovations in bioplastic manufacturing and heightened demand for biodegradable solutions further bolster the market’s growth trajectory, aligning with global efforts to reduce plastic waste and carbon footprints.

Growing public awareness of plastic waste and its negative environmental impact has resulted in an increased popularity of biobased biodegradable polymers. Customers as well as companies are looking for sustainable options that decrease plastic waste and protect the environment.

Globally, rigorous laws and regulatory frameworks are prohibiting single-use plastic and encouraging the usage of biodegradable materials. Adherence to these rules is a primary motivator, driving firms to use biobased biodegradable polymers for a variety of uses.

Many corporations are implementing biobased biodegradable polymers as an aspect of their corporate social duty programs. Sustainable practices in company practices improve the brand’s reputation and fulfill the needs of environmentally conscious customers.

Persistent bioplastic technological advancement is resulting in the invention of new and affordable recyclable materials. Manufacturing methods and material composition breakthroughs have broadened the practical usage of biobased biodegradable polymers.

Client preferences are evolving and there is a burgeoning eco-conscious customer base. Customers are favoring biodegradable plastic in items and packaging, prompting businesses to spend on those substances and fueling market growth.

Sustainability issues, tough restrictions, and customer preference for environment-friendly alternatives are driving considerable growth in the biobased biodegradable plastic industry in the United States.

The market has been propelled further by increasing public consciousness of plastic waste and an increasing focus on business sustainability practices.

The proactive involvement of the United Kingdom in Circular Economy frameworks has stimulated the emergence of bioplastic recycling facilities, offering new market prospects. Leading brands and retailers are switching to recyclable packaging, which is boosting the industry’s development.

Key Takeaways

The United States is estimated to be valued at USD 1.2 billion by 2033.
The market in the United Kingdom is predicted to expand at a 9.6% CAGR from 2023 to 2033.
The biobased biodegradable plastic market in the United Kingdom is projected to reach USD 400 million by 2033.
The biobased biodegradable plastic market in China is anticipated to be worth USD 1.4 billion.
The market in China is expected to record a CAGR of 10.1% through 2033.

“Partnership between the public and business sectors is going to encourage research and provide a steady supply of novel biodegradable products. Market dominance in emerging nations, combined with increased awareness of ecological issues globally, is expected to fuel market growth,” says an FMI analyst.

Navigate the Biobased Biodegradable Plastic Market Landscape with Expert Findings in the Complete Report!

Competitive Landscape

Competitiveness in the market fluctuates from minimal to considerable depending on area. Because of the enormous number of participants in Europe and North America, competition is moderate. On the other hand, due to limited market participants, competition in Asia Pacific is minimal.

Key market players are investing heavily in research and development to introduce revolutionary biodegradable plastic materials that are both sturdy and easily recyclable in the natural environment.

Futerro declared plans in December 2022 to build an initial vertically linked biorefinery in Europe in Normandy, France, for the manufacture and reusing of PLA.
NatureWorks held a ceremony in February 2023 to commemorate the completion of the organization’s Ingeo PLA production complex in Thailand.

Key Companies Profiled

BASF SE
Plantic Technologies
Toray Industries
Total Corbion PLA
Natureworks
Biome Bioplastic.
Bio-On
Mitsubishi Chemical Corporation
Danimer Scientific
Novamont S.P.A.

Biobased Biodegradable Plastic Market Report

Future Market Insights, in its new offering, presents an unbiased analysis of the global biobased biodegradable plastic market presenting a historical analysis from 2018 to 2022 and forecast statistics between 2023 and 2033.

The study reveals essential insights by Product Type (polyester, starch blends, poly lactic acid (PLA), cellulose, polyhydroxyalkanoate), Application (packaging, fibers, healthcare, agriculture, others), and Region.

About Future Market Insights (FMI)

Contact Us:

Joint Replacement Market to Hit USD 27 Billion by 2032 at a 4.3% of CAGR, Driven by Demand for Knee Replacement Procedures

The global joint replacement market is poised for substantial growth, with its valuation projected to rise from US$ 17.1 billion in 2021 to US$ 27 billion by 2032, according to a newly released analysis report by Future Market Insights. This expansion represents a compound annual growth rate (CAGR) of 4.3% from 2022 to 2032. The increasing prevalence of joint-related ailments and a growing aging population are key factors driving the growth of the joint replacement market.

Knee replacement is expected to be the highest revenue-generating segment in the market, with a projected CAGR of 4.1% from 2022 to 2032. The growing demand for knee replacement procedures can be attributed to the rising incidence of osteoarthritis, sports-related injuries, and degenerative joint diseases. Advancements in implant technology and minimally invasive surgical techniques are further boosting the adoption of knee replacement procedures globally.

As the population ages and the number of individuals suffering from joint disorders rises, the demand for joint replacement surgeries is expected to increase significantly. Innovations in prosthetic design, improved implant materials, and robotic-assisted surgical procedures are creating new growth opportunities for the market. Healthcare providers and manufacturers are also focusing on enhancing patient outcomes and reducing recovery times.

The joint replacement market is poised for sustained growth as healthcare providers, research organizations, and medical device companies continue to innovate and expand their offerings. With the rising adoption of robotic-assisted surgery and the development of more durable and long-lasting joint implants, the market is set to achieve strong growth over the next decade.

A Full Report Overview – https://www.futuremarketinsights.com/reports/joint-replacement-market

Key Takeaways:

The global joint replacement market is forecasted to grow from US$ 17.1 billion in 2021 to US$ 27 billion by 2032, with a CAGR of 4.3% from 2022 to 2032.
Knee replacement is expected to be the highest revenue-generating segment, growing at a CAGR of 4.1% over the forecast period.
Key growth drivers include the rising prevalence of osteoarthritis, advancements in implant technology, and the increasing use of robotic-assisted surgery.
The market is set to benefit from improved surgical techniques, enhanced patient outcomes, and growing healthcare investments in orthopedic care.

Market Drivers

Increasing Prevalence of Osteoarthritis and Joint Disorders: The rising incidence of osteoarthritis and other orthopedic injuries is driving demand for joint replacement surgeries.
Aging Population: An increasing geriatric population is more susceptible to joint-related issues, leading to higher demand for joint replacement procedures.
Technological Advancements: Continuous innovations in surgical techniques and implant materials are enhancing the effectiveness and safety of joint replacement surgeries.
Growing Awareness and Acceptance of Joint Replacement Procedures: Increased awareness about the benefits of joint replacement surgeries is encouraging more patients to seek treatment.
Rising Healthcare Expenditure: Increased spending on healthcare infrastructure and services supports the growth of the joint replacement market.

Regional Insights

North America: Expected to dominate the market due to high healthcare expenditure, advanced medical technology, and a significant number of orthopedic procedures performed.
Europe: Also shows strong growth potential, driven by an increasing elderly population and advancements in orthopedic implants.
Asia-Pacific: Anticipated to witness rapid growth as healthcare access improves and awareness regarding joint health increases.

Competitive Analysis

The joint replacement market is fragmented, with many large and small companies competing. Smith+Nephew, DJO, LLC, Johnson & Johnson Services Inc., Stryker, Zimmer Biomet, Arthrex Inc., Exactech Inc., Conformis, MicroPort Orthopedics, and Corin Group are some of the major players in the market.

Some of the recent developments of Joint Replacement Market key providers are as follows:

In January 2022, Engage Surgical, the owner of the only cement-less unicompartmental knee system commercially accessible in the United States, was acquired by Smith+Nephew, a multinational medical technology business.
In February 2021, MicroPort Orthopedics added hyaluronic acid-coated collared hip stems and affixed collared hip stems to their hip stems lineup.
In January 2021, Stryker purchased OrthoSensor, Inc., a forerunner in the digital evolution of full joint replacement.
In July 2018, Corin announced that it will offer the Trinity Dual Mobility System for Hip Replacement.

Market Segments Covered in Joint Replacement Market Analysis

By Replacement Type:

Extremities
- Upper
- Lower
Knees
Hips

By Fixation Type:

Cemented
Cementless
Hybrid
Reverse Hybrid

By End-use:

Hospitals
Orthopedic Clinics
Other End-uses

By Procedure Type:

Total Replacement
Partial Replacement
Other Procedure Types

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:

Direct-to-Consumer Genetic Testing Market
Biotherapeutics Virus removal filters Market
Oncology Information Systems Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Antacids Market Value Rise to Reach USD 11,194.8 Million by 2033 with a 4.9% of CAGR

The global antacids market is set to experience steady growth, with its valuation projected to rise from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, according to a recent report by Future Market Insights. This represents a compound annual growth rate (CAGR) of 4.9% over the forecast period. The rising prevalence of gastrointestinal disorders, increased demand for over-the-counter (OTC) digestive products, and a shift toward self-medication are key factors driving this expansion.

Proton pump inhibitors (PPIs) continue to dominate the antacids market, holding a substantial share of approximately 25.8% as of 2022. These inhibitors have become a preferred choice for managing conditions like heartburn and gastroesophageal reflux disease (GERD), which are on the rise due to changing dietary habits, stress, and sedentary lifestyles. The convenience and accessibility of OTC antacids have further fueled consumer demand.

The growing trend of self-medication and preference for OTC digestive health products is driving market growth. As consumers seek quick, cost-effective relief from gastrointestinal discomfort, the demand for antacids in tablet, liquid, and chewable form continues to increase. Retail pharmacies, online platforms, and supermarkets are playing a pivotal role in making these products more accessible to a broad consumer base.

The antacids market is poised for sustained growth as industry players introduce new formulations and flavors to enhance consumer experience. Pharmaceutical companies are also leveraging e-commerce platforms and direct-to-consumer sales channels to expand their reach. These developments are expected to create new growth opportunities for manufacturers, retailers, and healthcare providers in the coming decade.

Full Report Revealed – https://www.futuremarketinsights.com/reports/antacids-market

Key Takeaways:

The global antacids market is projected to grow from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, with a CAGR of 4.9%.
Proton pump inhibitors (PPIs) are leading the market, holding a 25.8% share as of 2022, driven by demand for effective solutions for GERD and heartburn.
Rising cases of gastrointestinal disorders and the growing trend of self-medication are key factors propelling demand for OTC digestive health products.
The introduction of innovative product formulations, combined with increased availability through retail and e-commerce channels, is driving further growth in the global antacids market.

Market Drivers

Increase in Gastrointestinal Disorders: The rising prevalence of conditions such as heartburn and gastroesophageal reflux disease (GERD) is significantly driving the demand for antacids.
Growing Self-Medication Trend: There is an increasing trend towards self-medication, leading to a higher demand for over-the-counter (OTC) digestive products.
Awareness Campaigns: Initiatives aimed at raising awareness about gastrointestinal health and available treatment options are contributing to market growth.
Accessibility of Antacids: The widespread availability of antacid products in pharmacies and retail outlets enhances consumer access and drives sales.

Competitive Landscape

The market for the production of antacids is fragmented, with several competitors. These businesses are employing strategies including collaborations, partnerships, mergers and acquisitions, and new drug releases to satisfy consumer demand and increase their client base.

Recent Development

On 6 June 2023, The US Food and Drug Administration (FDA) gave final approval to Zydus Lifesciences to market Famotidine tablets in dosages of 20 mg and 40 mg.
On 22 February 2023, GSK announced Haleon to be the name of its independent consumer healthcare company.
Similarly, recent developments related to pharmaceutical companies manufacturing antacids have been tracked by the team at Future Market Insights, which are available in the full report.

Key Companies Profiled

Johnson and Johnson
Sanofi S.A.
Bayer AG
Sun Pharmaceuticals Ltd
Zydus Lifesciences
Abbott Laboratories
AstraZeneca plc
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Procter & Gamble Company
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Limited.
F. Hoffmann-La Roche Ltd
Mylan N.V
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Fresenius Kabi AG
Alkem Labs.

Key Market Segments Covered in Antacids Industry Research

By Drug Class:

Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
Anti-H.Pyrolic Drugs
Prostaglandin Analogous
Others

By Dosage form:

Tablet
Capsules
Powder
Liquid
Others

By Route of Administration:

Oral
Injectable

By Indication:

Gastroesophageal Reflux Disease
Heartburn
Peptic Ulcer
Others

By Distribution channel:

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)

Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:

Airway Clearance Devices System Market
Mobile Operating Rooms Market
Ovulation Microscope Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube